HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

TAE226

an adhesion kinase inhibitor, offers an attractive therapeutic approach in ovarian carcinoma; structure in first source
Networked: 20 relevant articles (5 outcomes, 5 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Takaoka, Munenori: 7 articles (01/2015 - 07/2008)
2. Hatakeyama, Shinji: 7 articles (01/2015 - 04/2007)
3. Naomoto, Yoshio: 7 articles (01/2015 - 07/2008)
4. Fukazawa, Takuya: 4 articles (11/2012 - 12/2008)
5. Yamatsuji, Tomoki: 4 articles (07/2012 - 07/2008)
6. Sakurama, Kazufumi: 4 articles (07/2012 - 07/2008)
7. Ohmori, Osamu: 4 articles (01/2009 - 04/2007)
8. Tomono, Yasuko: 3 articles (07/2012 - 07/2008)
9. Watanabe, Nobuyuki: 3 articles (01/2009 - 07/2008)
10. Motoki, Takayuki: 3 articles (01/2009 - 07/2008)

Related Diseases

1. Breast Neoplasms (Breast Cancer)
2. Glioma (Gliomas)
3. Esophageal Neoplasms (Esophageal Cancer)
4. Carcinoma (Carcinomatosis)
5. Adenocarcinoma

Related Drugs and Biologics

1. Focal Adhesion Protein-Tyrosine Kinases
2. Protein-Tyrosine Kinases (Tyrosine Kinase)
3. Dihydrotachysterol (AT 10)
4. Phosphotransferases (Kinase)
5. pyrimidine
6. Cyclin B1
7. Small Interfering RNA (siRNA)
8. IGF Type 1 Receptor (IGF 1 Receptor)
9. Urea (Carbamide)
10. Ribosomal Proteins (Ribosomal Protein)

Related Therapies and Procedures

1. Oral Administration
2. Heterologous Transplantation (Xenotransplantation)
3. Drug Therapy (Chemotherapy)